For more than 50 years, I have taken care of thousands of patients with lymphoma and other blood cancers, while at the same time, trying to unlock the mysteries of these diseases through research.
Since coming to the Cancer Institute of New Jersey in 2002, I have collaborated with top experts in the field to help develop the latest generation of cancer treatments. I have had a special research interest in developing new drugs and understanding why drugs work or don't work, and I am currently exploring new treatments for one type of lymphoma, namely T- Cell lymphoma. By having the resources available that can only be found at a National Cancer Institute-designated Comprehensive Cancer Center, our team is able to translate these research findings and directly apply them to patient therapies.
With a clinical expertise in lymphoma, I work closely with colleagues across all disciplines at the Cancer Institute, including those within the Leukemia/Lymphoma/Hematologic Malignancies Program, to educate patients about the treatment options available to them.
I completed a USPHS fellowship (in hematology/oncology) at University of Washington School of Medicine. I am a member of the Board of the Lymphoma Research Foundation, which administers grants to promising young investigators. I am the author or co-author of more than 400 scientific publications and I am the associate medical editor of the journal Hem/Onc Today.